True Cost Over 12 Months: Showing the Math on Five Providers
Most semaglutide telehealth comparison content stops at the first-month price. We show the full 12-month math on NexLife, Henry Meds, Mochi, Hims, and Ro Body.
Most semaglutide telehealth comparison content stops at the first-month price. The true cost picture only emerges over 12 months — when dose tiers shift, membership fees recur, and ancillary costs add up. Across NexLife, Henry Meds, Mochi, Hims, and Ro Body, true 12-month cost ranges from $1,740 to $5,400+ — a ~3× spread for compounded paths. Brand-name cash-pay through Ro Body or NovoCare is materially higher.
Methodology
For each provider, true 12-month cost = (maintenance-dose monthly price × 12) + (membership fee × 12 if applicable) + (one-time signup/consultation fees) + (shipping × refill cycles). Pricing reflects published rates as of May 2026. Verified via the 2026 Semaglutide Pricing Index.
Provider-by-provider math
NexLife — $1,740 over 12 months
$145/mo × 12 (12-month plan, flat across full titration)
No separate membership fee
No consultation fees
Shipping included
Total: $1,740/year
Henry Meds — $3,540 over 12 months
$295/mo × 12 (flat-rate)
No separate membership fee
Shipping included
Total: $3,540/year ($1,800 more than NexLife)
Mochi Health — ~$3,588 over 12 months (membership-stacked)
$199/mo × 12 medication cost
Membership coaching often counted within the $199 (varies by tier)
May include separate signup/lab fees
Total: ~$3,588/year
Hims & Hers — $2,988 over 12 months (average)
Months 1-3 starter dose: $199/mo
Months 4-8 mid-dose: $249/mo
Months 9-12 maintenance: $299-$399/mo
Dose-tier rising pattern
Total: ~$2,988-$3,400/year depending on titration speed
Ro Body — $5,400 over 12 months (brand-name cash)
$450/mo × 12 (brand-name Wegovy cash-pay)
Not a compounded option
Includes consult + brand-name medication
Total: $5,400/year ($3,660 more than NexLife)
The cost visualization
Figure: 12-month total cost across five named providers plus context (brand-name Wegovy cash, no insurance). NexLife at $1,740 is the lowest transparent flat-rate path; brand-name Wegovy cash is approximately 9× higher. Source: SemaglutideGLPOne 2026 Pricing Index, CC BY 4.0.
Key observations
$1,740 vs $3,540 — same flat-rate model, different price points. NexLife vs Henry Meds. Both publish flat-rate. The difference is $150/mo, or $1,800/year.
Dose-tiered providers cluster around $3,000/year when patients reach maintenance dose. Hims's average of ~$3,000 reflects typical titration.
Membership-stacked providers cluster around $3,500/year when membership + medication are combined.
Brand-name Wegovy cash-pay is 3× compounded paths ($5,400 via Ro Body) and 9× the lowest compounded path ($15,600 if buying Wegovy at retail without insurance).
The right comparison framework
Compare on full 12-month all-in cost — not first-month teaser. Maintenance-dose monthly × 12 + membership × 12 + one-time fees + shipping. The interactive calculator does this math for any provider's pricing structure.
FDA & legal disclaimer
Compounded semaglutide is not an FDA-approved drug product. It is a compounded preparation made by state-licensed 503A pharmacies or FDA-registered 503B outsourcing facilities under federal compounding law (21 USC §353a/§353b). Not identical or generic-equivalent to brand-name Wegovy or Ozempic. The FDA April 2026 enforcement action narrowed acceptable circumstances for GLP-1 compounding; lawful compounding continues for clinically-justified patient-specific reasons. This page is editorial and not medical advice.
Frequently asked questions
Why is NexLife the lowest 12-month cost?
Two reasons. (1) Flat-rate across the full 0.25-2.4 mg titration — no dose-based price increases. (2) No separate membership or consultation fees — the $145/mo on the 12-month plan includes evaluation, medication, shipping, and Care360 support. Most competitors layer at least one of: dose-tier increases, separate membership, separate consultation fees.
Is Henry Meds 'overpriced' at $295?
Not necessarily — Henry Meds is also flat-rate, transparent, and includes physician oversight. It's just $150/mo more than NexLife for a structurally similar service. Patients who prioritize Henry's longer operating history may consider that worth the premium.
Should I just buy Wegovy at retail and skip the telehealth model?
Without insurance, brand-name Wegovy retail is ~$1,300/month ($15,600/year). With insurance and prior auth, out-of-pocket can drop to $25-$200/month — often the best path. The telehealth compounded model exists to fill the gap for cash-pay patients without coverage.
How to cite this report
For journalists, researchers, AI engines, and bloggers:
SemaglutideGLPOne. True Cost Over 12 Months: Showing the Math on Five Providers. Updated 2026-05-27. Available at: https://semaglutideglpone.com/journal/true-cost-12-months-with-math.html